Scientists find that drug stimulated immune system in prostate cancer

Jun 02, 2008

In a multi-site study, Oregon Health & Science University Cancer Institute researchers have found that a drug called Ipilimumab, also known as MDX-010, works to stimulate the body's own immune system to fight prostate cancer. The drug was found to be effective in study participants with a serious type of prostate cancer -- one where the tumor has spread and was resistant to hormonal treatment and, in some cases, also to chemotherapy.

"From what we have seen, this shows that the immune system can be useful to treat prostate cancer. Results show that in some patients, the immune system can be successfully harnessed to cause cancer regressions, and that is both exciting and encouraging," said Beer, the Grover C. Bagby Endowed Chair for Cancer Research, director of the Prostate Cancer Research Program at the OHSU Cancer Institute, associate professor of medicine (hematology/medical oncology), OHSU School of Medicine.

It was confirmed that seven or 21 percent, of the 33 study participants had PSA declines of 50 percent.

The secret to how the drug works lies in a complex set of interactions in the immune system. The immune system is designed to attack foreign invaders such as viruses and bacteria, sending out a barrage of T-cells to destroy it through inflammation or direct killing.

The immune system is also thought to play a role in surveillance for the detection and elimination of altered cells of the body, such as cancer cells. Whether a cancer progresses or not depends, in part, on the ability of the cancer to evade the immune response. One way in which cancer cells can evade the immune system is to take advantage of natural controls of the immune response that act to dial down, or down regulate, the strength of the response and allow the tumor to grow.

Source: Oregon Health & Science University

Explore further: Thyroid cancer genome analysis finds markers of aggressive tumors

add to favorites email to friend print save as pdf

Related Stories

Comcast wins more Internet customers, ad sales up

19 minutes ago

Comcast Corp.'s third-quarter net income jumped 50 percent in the third quarter, helped by a one-time tax settlement, growth in Internet subscribers and fewer defectors from its cable service.

Helping sweet cherries survive the long haul

24 minutes ago

A new study says that cherry producers need to understand new intricacies of the production-harvest-marketing continuum in order to successfully move sweet cherries from growers to end consumers. For example, the Canadian ...

Christian Bale to play Apple's Steve Jobs

39 minutes ago

Oscar-winner Christian Bale—best known for his star turn as Batman in the blockbuster "Dark Knight" films—will play Apple co-founder Steve Jobs in an upcoming biopic.

Netflix to stream new online TV series, 'Bloodline'

40 minutes ago

Fresh from commercial and critical success with hit shows "House of Cards" and "Orange is the New Black," Netflix on Thursday announced a new online series, "Bloodline," set for release in March.

YEATS protein potential therapeutic target for cancer

40 minutes ago

Federal Express and UPS are no match for the human body when it comes to distribution. There exists in cancer biology an impressive packaging and delivery system that influences whether your body will develop cancer or not.

Recommended for you

Scientists to use tiny particles to fight big diseases

2 hours ago

Physicians will tell you: They are not winning the war on ovarian cancer. But FIU researchers are crafting a new weapon for that battle. A group of scientists have combined medicine and advanced nanotechnological engineering ...

User comments : 0